Henrik Hasle

  1. Participation in or organisation af a conference
  2. International summer school in pediatrics.

    Henrik Hasle (Organizer)

    29 Jun 200921 Aug 2009

    Activity: Participating in or organising an event typesParticipation in or organisation af a conference

  3. U-kursus i hæmatologi/onkologi for pædiatere

    Henrik Hasle (Participant)

    10 Nov 2009 → …

    Activity: Participating in or organising an event typesParticipation in or organisation af a conference

  4. Participation in or organisation of workshop, seminar or course
  5. I-BFM-AML-SG biannual meeting

    Henrik Hasle (Organizer)

    20 May 2019

    Activity: Participating in or organising an event typesParticipation in or organisation of workshop, seminar or course

  6. I-BFM-AML-SG biannual meeting

    Henrik Hasle (Organizer)

    7 Dec 2019

    Activity: Participating in or organising an event typesParticipation in or organisation of workshop, seminar or course

  7. Lecture and oral contribution
  8. 7th meeting of EBMT

    Henrik Hasle (Invited speaker)

    2 Jun 2010

    Activity: Talk or presentation typesLecture and oral contribution

  9. ALL case with a leukemoid reaction/MDS 16 months before ALL.

    Henrik Hasle (Lecturer)

    21 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  10. AML - Fra tidlig død til langtidsoverlevere. En nordisk succeshistorie.

    Henrik Hasle (Lecturer)

    6 Jun 2008

    Activity: Talk or presentation typesLecture and oral contribution

  11. AML hos børn

    Henrik Hasle (Lecturer)

    26 Oct 2011

    Activity: Talk or presentation typesLecture and oral contribution

  12. AML in children. Indications for SCT in the Nordic countries. EBMT 35th annual meeting, Göteborg, Marts 30, 2009.

    Henrik Hasle (Lecturer)

    30 Mar 2009

    Activity: Talk or presentation typesLecture and oral contribution

  13. AML treatment and complications: 2nd vietnamese course in pediatric oncology.

    Henrik Hasle (Lecturer)

    9 Feb 2012

    Activity: Talk or presentation typesLecture and oral contribution

  14. Advanced MDS in children.: Diagnosis and management.

    Henrik Hasle (Lecturer)

    26 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  15. Annual meeting of the international BFM study

    Henrik Hasle (Invited speaker)

    3 Oct 2010

    Activity: Talk or presentation typesLecture and oral contribution

  16. Annual meeting of the international BFM study group

    Henrik Hasle (Invited speaker)

    3 Oct 2010

    Activity: Talk or presentation typesLecture and oral contribution

  17. Bone Marrow Failure Syndromes

    Henrik Hasle (Lecturer)

    8 Apr 2008

    Activity: Talk or presentation typesLecture and oral contribution

  18. Chairman for sessionen Bone marrow failure and childhood MDS.

    Henrik Hasle (Lecturer)

    22 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

  19. Curative therapy of childhood MDS and JMML. ESO - Euroconference on myelodysplastic syndromes.

    Henrik Hasle (Lecturer)

    24 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

  20. Diagnosis and classification of childhood MDS. ESO - Euroconference on myelodysplastic syndromes.

    Henrik Hasle (Lecturer)

    22 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

  21. Diagnosis and management of children with MDS and JMML.

    Henrik Hasle (Lecturer)

    10 Jun 2011

    Activity: Talk or presentation typesLecture and oral contribution

  22. Diagnostics and classification of patients with MDS and myeloproliferative disorders

    Henrik Hasle (Lecturer)

    6 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  23. Early detection of molecular relapse in AML and possible consequences.: Childhood Leukemia Symposium

    Henrik Hasle (Lecturer)

    23 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  24. Early detection of molecular relapse in pediatric AML.

    Henrik Hasle (Lecturer)

    7 Dec 2012

    Activity: Talk or presentation typesLecture and oral contribution

  25. Hyperleukocytosis-Tumor lysis syndrome: 2nd Vietnamese course in pediatric oncology.

    Henrik Hasle (Lecturer)

    9 Feb 2012

    Activity: Talk or presentation typesLecture and oral contribution

  26. Individualized treatment for patients with JMML

    Henrik Hasle (Lecturer)

    5 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  27. International Standards for diagnostics in AML in 2012.: Childhood Leukemia Symposium

    Henrik Hasle (Lecturer)

    23 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  28. JMML

    Henrik Hasle (Lecturer)

    25 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  29. Mumbai Haematology Group Annual Meeting

    Henrik Hasle (Invited speaker)

    7 Mar 2010

    Activity: Talk or presentation typesLecture and oral contribution

  30. Mumbai Haematology Group Annual Meeting

    Henrik Hasle (Invited speaker)

    7 Mar 2010

    Activity: Talk or presentation typesLecture and oral contribution

  31. Myelodysplastic Syndrome

    Henrik Hasle (Lecturer)

    6 Mar 2008

    Activity: Talk or presentation typesLecture and oral contribution

  32. Myeloid malignancies in Down syndrome

    Henrik Hasle (Lecturer)

    25 Mar 2001

    Activity: Talk or presentation typesLecture and oral contribution

  33. NFCG meeting

    Henrik Hasle (Invited speaker)

    4 Feb 2010

    Activity: Talk or presentation typesLecture and oral contribution

  34. NOPHO AML teatment and outcome.

    Henrik Hasle (Lecturer)

    14 Apr 2011

    Activity: Talk or presentation typesLecture and oral contribution

  35. NOPHO-AML current status

    Henrik Hasle (Lecturer)

    18 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  36. Overview of childhood AML. Paediatric Strategy Forum for Medicinal Product Development for AML in Children and Adolescents

    Henrik Hasle (Lecturer)

    11 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  37. Pre-emptive treatment of relapsed in AML with azacitidine.

    Henrik Hasle (Lecturer)

    21 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  38. Refractory cytopenia in children. Diagnosis and management.

    Henrik Hasle (Lecturer)

    24 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  39. SCT in children with AML indications and results.

    Henrik Hasle (Lecturer)

    15 Oct 2011

    Activity: Talk or presentation typesLecture and oral contribution

  40. SCT in high-risk AML. Best of I-BFM-SG. SIOP annual meeting.

    Henrik Hasle (Lecturer)

    9 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

  41. Samtaler med alvorlig syke barn og deres foreldre.

    Henrik Hasle (Lecturer)

    5 Feb 2009

    Activity: Talk or presentation typesLecture and oral contribution

  42. Unique pattern of leukemia in Down syndrome. Disparities and Outcomes in Acute Leukemia.

    Henrik Hasle (Lecturer)

    4 Nov 2019

    Activity: Talk or presentation typesLecture and oral contribution

  43. Vidaza program in myeloid leukemia.

    Henrik Hasle (Lecturer)

    18 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  44. Consultancy
  45. Controversies in indications

    Henrik Hasle (Advisor)

    2 Jun 2010

    Activity: Consultancy typesConsultancy

  46. Membership in committee, council, board
  47. American Society of Hematology; ICM - ASH (External organisation)

    Henrik Hasle (Member)

    2013 → …

    Activity: Membership typesMembership in committee, council, board

  48. Bestyrelsesmedlem af DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Mar 2006 → …

    Activity: Membership typesMembership in committee, council, board

  49. DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Mar 2007 → …

    Activity: Membership typesMembership in committee, council, board

  50. Dansk Hæmatologisk Selskabs Transplantationsudvalg (External organisation)

    Henrik Hasle (Member)

    1 Jul 2008 → …

    Activity: Membership typesMembership in committee, council, board

  51. Dansk leukæmi/lymfom specialgruppe under DAPHO (External organisation)

    Henrik Hasle (Member)

    1 Jan 2004 → …

    Activity: Membership typesMembership in committee, council, board

  52. Formand for NOPHO AML-gruppen. Principal investigator af NOPHO-AML 2004 protokollen. (External organisation)

    Henrik Hasle (Member)

    1 Feb 2002 → …

    Activity: Membership typesMembership in committee, council, board

  53. Formand for NOPHO leukaemia lymphoma working group. (External organisation)

    Henrik Hasle (Member)

    1 Jun 2008 → …

    Activity: Membership typesMembership in committee, council, board

  54. Formand for speciallægerådet i pædiatri i Region Midt. (External organisation)

    Henrik Hasle (Member)

    1 Jan 2007 → …

    Activity: Membership typesMembership in committee, council, board

  55. I-BFM SG The International BFM Study Group (External organisation)

    Henrik Hasle (Chairman)

    2016 → …

    Activity: Membership typesMembership in committee, council, board

  56. Koordinator for de nordiske lande for den prospektive EWOG-MDS undersøgelse (External organisation)

    Henrik Hasle (Member)

    1 Jun 1993 → …

    Activity: Membership typesMembership in committee, council, board

  57. NOPHO (External organisation)

    Henrik Hasle (Member)

    14 May 2008 → …

    Activity: Membership typesMembership in committee, council, board

  58. NOPHO-AML 2004 protokollen (External organisation)

    Henrik Hasle (Member)

    1 Jan 2004 → …

    Activity: Membership typesMembership in committee, council, board

  59. Specialerådet i pædiatri i Region Midt (External organisation)

    Henrik Hasle (Member)

    1 Jan 2007 → …

    Activity: Membership typesMembership in committee, council, board

  60. Membership in board of company or public organisation
  61. European Society of Paediatric Oncology (SIOPE) (External organisation)

    Henrik Hasle (Member)

    2012 → …

    Activity: Membership typesMembership in board of company or public organisation

  62. Pediatric Blood & Cancer (External organisation)

    Henrik Hasle (Member)

    2009 → …

    Activity: Membership typesMembership in board of company or public organisation

  63. Membership in review committee
  64. Aarhus University (External organisation)

    Henrik Hasle (Member)

    22 Jun 2015

    Activity: Membership typesMembership in review committee

  65. Aarhus University (External organisation)

    Henrik Hasle (Member)

    30 Oct 2015

    Activity: Membership typesMembership in review committee

  66. Bedømmelse af PhD afhandling. (Event)

    Henrik Hasle (Member)

    18 Sep 2019

    Activity: Membership typesMembership in review committee

  67. Bedømmelse af PhD afhandling. (Event)

    Henrik Hasle (Member)

    3 Jul 2019

    Activity: Membership typesMembership in review committee

  68. Department of Clinical Medicine - Department of Paediatrics (Organisational unit)

    Henrik Hasle (Member)

    13 Nov 2020

    Activity: Membership typesMembership in review committee

  69. Udvalg (External organisation)

    Henrik Hasle (Member)

    1 Aug 200612 Jan 2007

    Activity: Membership typesMembership in review committee

  70. Other
  71. AML: New approaches in diagnostics - new targets for therapy.

    Henrik Hasle (Participant)

    5 Oct 2010

    Activity: Other activity typesOther

  72. Central nervous system involvement in childhood acute lymphoblastic leukemia

    Henrik Hasle (Participant)

    13 Dec 2016

    Activity: Other activity typesOther

  73. MRD in AML: Annual meeting of the International BFM study group.

    Henrik Hasle (Participant)

    3 Oct 2010

    Activity: Other activity typesOther

  74. Mental late effect in childhood cancer survivors and their siblings.

    Henrik Hasle (Participant)

    1 Nov 2013

    Activity: Other activity typesOther

  75. The molecular heterogeneity of MML rearranged pediatric AML.

    Henrik Hasle (Participant)

    26 Jun 2013

    Activity: Other activity typesOther

  76. Other (prizes, external teaching and other activities) - External teaching and subject coordination
  77. Late effect of cancer at a young age.: Registrybased studies of the health of cancer patients and their offspring.

    Henrik Hasle (Participant)

    4 Mar 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination

  78. The effects of a controlled family nurse directed intervention program for parents hospitalized with children undergoing allogenic haematopoietic stem cell transplantation.

    Henrik Hasle (Participant)

    8 Nov 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination

  79. Venous and arterial thromboembolism in children and adolescents in Denmark 1994-2006.

    Henrik Hasle (Participant)

    11 Nov 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination